Monthly Prescribing Reference1h
Antidepressant Recalled Due to Presence of Nitrosamine Impurity
N-nitroso-duloxetine belongs to the nitrosamine class of compounds, some of which are classified as probable or possible human carcinogens.
Thousands of bottles of popular antidepressant recalled: 3 things to know
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National ...
FDA recalls over 7,000 bottles of antidepressant due to possible cancerous chemical
The FDA has recalled thousands of bottles of the antidepressant duloxetine, sold under brand name Cymbalta, due to the ...
ConsumerAffairs4h
FDA recalls thousands of bottles of antidepressants over toxic chemicals
The Food and Drug Administration (FDA) has recalled over 7,000 bottles of the popular antidepressant duloxetine – sold under ...
FDA recalls more than 7,000 bottles of antidepressant duloxetine over toxic chemical
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant duloxetine over the presence of ...
7,000 Bottles Of Antidepressants Recalled By FDA Over Possible Presence Of Cancerous Chemical
The FDA recalled more than 7,000 bottles of an antidepressant due to the presence of a carcinogenic chemical. The ...
FDA recalls over 7,000 bottles of antidepressant duloxetine
The recall was initiated due to the discovery of N-nitroso-duloxetine, a chemical impurity classified as a nitrosamine.
Becker's Hospital Review7h
FDA recalls 7,000 antidepressant bottles
The FDA's recall involves 7,107 bottles containing 500 delayed-release 20 milligram duloxetine capsules, which are prescribed to treat conditions such as anxiety, depression, nerve pain related to ...
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the ...
Le Lézard7h
AbbVie and Gedeon Richter Announce New Collaboration for the Discovery and Development of Novel Targets for Neuropsychiatric Conditions
AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.
Is there a 2024 Duloxetine recall? FDA flags 7,100+ bottles of generic Cymbalta antidpressants
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.
Antidepressants turned me into a raging alcoholic and I'm not alone: The little-known side-effect that ruins lives revealed by experts - plus who is most likely to suffer and ...
When high-flying lawyer Tony Green's GP suggested he try antidepressants, he had no idea that they would leave him with a drink problem.